Brief: Osteopore Enters A$4.0 Mln Collaboration, Clinical Research And Implementation Partnership
07/06/2023 23:58
June 8 (Reuters) - Osteopore Ltd OSX.AX :
* AUD$4.0M COLLABORATION, CLINICAL RESEARCH AND
IMPLEMENTATION
PARTNERSHIP FOR CHINESE MARKET
* PARTNERSHIP TO WORK TOWARDS COMMERCIALISING OSTEOPORE'S
REGENERATIVE IMPLANT TECHNOLOGY ACROSS CHINA, HONG KONG, MACAU,
AND TAIWAN
Source text for Eikon: ID:nASX7DgpwZ
Further company coverage: OSX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Osteopore
See all newsBrief: Osteopore Secures Market Access In Thailand For Full Range Of Orthopaedic Products
Brief: Osteopore Strikes Orthopaedic Deal For 5 Middle East Countries
Brief: Osteopore Achieves Market Access To Saudi Arabia For Craniofacial Products
Brief: Osteopore Launches Clinical Study For Paranasal Augmentation In Patients With Unilateral Cleft Lip
Australia's Osteopore advances on regulatory win in China's Hainan